Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FZX69
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,642
Award facts
- Contract value 100% obligated
- $4,642.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,642.20 to DMS Pharmaceutical Group Inc. for XOLAIR 150 MG/ML Syringe on August 22, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. XOLAIR (omalizumab) is a monoclonal antibody used primarily for treating moderate-to-severe allergic asthma and chronic idiopathic urticaria, representing a specialized pharmaceutical product within the broader federal healthcare supply chain.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion vehicle valid through November 2026. The IDC enables DLA to procure an extensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier to federal military health facilities through consistent contract performance and its comprehensive pharmaceutical distribution capabilities.
Quick answers
Who was awarded contract SPE2DB25FZX69?
SPE2DB25FZX69 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FZX69 worth?
The government has obligated $4,642 on SPE2DB25FZX69.
Is contract SPE2DB25FZX69 an order under another contract?
Yes. SPE2DB25FZX69 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX69 competed?
The extent of competition for SPE2DB25FZX69 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award